X

VTRS

Viatris Inc (VTRS) Sec Form 10K

Viatris Inc (NASDAQ: VTRS) Sec Form 10K

Viatris Inc (VTRS) Sec Form 8K

Viatris Inc (NASDAQ: VTRS) Sec Form 8K

Viatris Inc (VTRS) Dividend Update

Viatris Inc (NASDAQ: VTRS) Q1 2026 Dividend Update

Viatris Inc (VTRS) Q4 2025 Earnings Results

Viatris Inc (NASDAQ: VTRS) Q4 2025 Earnings Release

Viatris Inc (VTRS) Q4 2025 Earnings Call

Viatris Inc (NASDAQ: VTRS) Q4 2025 Earnings Conference

Viatris Inc (VTRS) FDA Accepts Viatris Supplemental New Drug Application for MR-141 (Phentolamine Ophthalmic Solution 0.75%) for the Treatment of Presbyopia

Viatris Inc (NASDAQ: VTRS) FY 2026 Other Release

Viatris Inc (VTRS) Q1 2021 Earnings Call Transcript

Viatris Inc (NASDAQ: VTRS) Q1 2021 Earnings Call dated May. 10, 2021 Corporate Participants: Melissa Trombetta — Head of Global…

Viatris Inc (VTRS) Q2 2025 Earnings Call Transcript

Viatris Inc (NASDAQ: VTRS) Q2 2025 Earnings Call dated Aug. 07, 2025 Corporate Participants: Bill Szablewski — Investor Relations Scott…

Viatris Inc (VTRS) Q3 2025 Earnings Call Transcript

Viatris Inc (NASDAQ: VTRS) Q3 2025 Earnings Call dated Nov. 06, 2025 Corporate Participants: Bill Szablewski — Investor Relations Scott…

Viatris (VTRS) posts Q3 2025 results and updates 2025 guidance

Pharmaceuticals company Viatris Inc. (NASDAQ: VTRS) on Thursday reported financial results for the third quarter of fiscal 2025, and updated…